Skip to main content

Female Sexual Dysfunction

Is There a Magic Pill?

  • Chapter
Oral Pharmacotherapy for Male Sexual Dysfunction

Part of the book series: Current Clinical Urology ((CCU))

  • 572 Accesses

Abstract

Female sexual dysfunction (FSD) is a complex set of conditions associated with multiple anatomical, physiological, biological, medical, and psychological factors. It can be age-related and appears to be highly prevalent, affecting 20 to 50% of women (1). Data from the National Health and Social Life Survey (NHSLS), a large representative sample of US women, reported that one-third of women experienced loss of sexual interest, and nearly one-fourth reported lack of orgasm during the past year (2). Sexual dysfunctions are associated with problems of mood, self-esteem, quality of life, emotional distress, and relationship difficulties (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Basson R, Berman J, Burnett A, et al. (2000) Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163:888–893.

    Article  PubMed  CAS  Google Scholar 

  2. Laumann EO, Paik A, Rosen RC. (1999) Sexual dysfunction in the United States: prevalence and predictors. JAMA 281:537–544.

    Article  PubMed  CAS  Google Scholar 

  3. Berman JR, Goldstein I. (2001) Female sexual dysfunction. Urol Clin North Am 28:405–416.

    Article  PubMed  CAS  Google Scholar 

  4. Kaplan HS. (1974) The New Sex Therapy. New York, NY: Brunner Mazel.

    Google Scholar 

  5. Masters WH, Johnson VE. (1970) Human Sexual Inadequacy. Boston, MA: Little Brown, pp. 214–315.

    Google Scholar 

  6. Rosen RC. (2000) Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2:189–195.

    Article  PubMed  CAS  Google Scholar 

  7. American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Ed., Washington, DC: American Psychiatric Press, pp. 543, 544,547–549,554–565.

    Google Scholar 

  8. World Health Organization. (1992) International Statistical Classification of Diseases and Related Health Problems, 10th Ed., Geneva, Switerland: World Health Organization, pp. 355–356.

    Google Scholar 

  9. Basson R. (2000) The female sexual response: a different model. J Sex Marital Ther 26:51–65.

    Article  PubMed  CAS  Google Scholar 

  10. Berman JR, Bassuk J. (2002) Physiology and pathophysiology of female sexual function and dysfunction. World J Urol 20:111–118.

    Article  PubMed  Google Scholar 

  11. Goldstein I, Berman JR. (1998) Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot Res 10(Suppl 2):S84–S90; discussion S98–S101.

    PubMed  Google Scholar 

  12. Berman JR, Berman L, Goldstein I. (1999) Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology 54:385–391.

    Article  PubMed  CAS  Google Scholar 

  13. Sipski ML, Rosen RC, Alexander CJ, et al. (2000) Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury. Urology 55:812–815.

    Article  PubMed  CAS  Google Scholar 

  14. Shafik A. (2000) The role of the levator ani muscle in evacuation, sexual performance and pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 11:361–376.

    Article  PubMed  CAS  Google Scholar 

  15. Weber AA. (1999) Effects of estrogens and androgens on the libido of women following surgical and natural menopause. Menopausal Med 7:5–8.

    Google Scholar 

  16. Berman JR, McCarthy MM, Kyprianou N. (1998) Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina. Urology 51:650–656.

    Article  PubMed  CAS  Google Scholar 

  17. Laan E, van Lunsen RH. (1997) Hormones and sexuality in postmenopausal women: a psychophysiological study. J Psychosom Obstet Gynaecol 18:126–133.

    PubMed  CAS  Google Scholar 

  18. Kow LM, Pfaff DW. (1973) Effects of estrogen treatment on the size of receptive field and response threshold of pudendal nerve in the female rat. Neuroendrocrinology 13:299–313.

    Article  Google Scholar 

  19. Greendale GA, Lee NP, Arriola ER. (1999) The menopause. Lancet 353:571–580.

    Article  PubMed  CAS  Google Scholar 

  20. Davis SR, Tran J. (2001) Testosterone influences libido and well being in women.Trends Endocrinol Metab 12:33–37.

    Article  PubMed  CAS  Google Scholar 

  21. Dennerstein L, Dudley E, Burger H. (2001) Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 76:456–460.

    Article  PubMed  CAS  Google Scholar 

  22. Traish AM, Kim N, Min K, et al. (2002) Androgens in female genital sexual arousal function: a biochemical perspective. J Sex Marital Ther 28(Suppl 1):233–244.

    Article  PubMed  Google Scholar 

  23. Vierhapper H, Nowotny P, Waldhausl W. (1997) Determination of testosterone production rates in men and women using stable isotope/dilution and mass spectrometry. J Clin Endocrinol Metab 82:1492–1496.

    Article  PubMed  CAS  Google Scholar 

  24. Mathur RS, Landgrebe SC, Moody LO, et al. (1985) The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. Maturitas 7:129–133.

    Article  PubMed  CAS  Google Scholar 

  25. Rosen RC, Lane RM, Menza M. (1999) Effects of SSRI’s on sexual function: a critical review. J Clin Psychopharmacol 19:67–85.

    Article  PubMed  CAS  Google Scholar 

  26. Coleman CC, King BR, Bolden-Watson C, et al. (2001) A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 23:1040–1058.

    Article  PubMed  CAS  Google Scholar 

  27. Rosen RC, Leiblum SR. (1995) Treatment of sexual disorders in the 1990s: an integrated approach. J Consult Clin Psychol 63:877–890.

    Article  PubMed  CAS  Google Scholar 

  28. Burchardt M, Burchardt T, Anastasiadis AG, et al. (2002) Sexual dysfunction is common and overlooked in female patients with hypertension. J Sex Marital Ther 28:17–26.

    Article  PubMed  Google Scholar 

  29. Stuart FM, Hammond DC, Pett MA. (1987) Inhibited sexual desire in women. Arch Sex Behav 16:91–106.

    Article  PubMed  CAS  Google Scholar 

  30. Dunn KM, Croft PR, Hackett GI. (1998) Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 15:519–524.

    Article  PubMed  CAS  Google Scholar 

  31. Rosen RC, Taylor JF, Leiblum SR, et al. (1993) Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther 19:171–188.

    PubMed  CAS  Google Scholar 

  32. Heimann JR, Grafton-Becker V. (1989) Orgasmic disorders in women. New York, NY: Guidford Press.

    Google Scholar 

  33. Jamieson DJ, Steege JF. (1996) The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 87:55–58.

    Article  PubMed  CAS  Google Scholar 

  34. Shokrollahi P, Mirmohamadi M, Mehrabi F, et al. (1999) Prevalence of sexual dysfunction in women seeking services at family planning centers in Tehran. J Sex Marital Ther 25:211–215.

    Article  PubMed  CAS  Google Scholar 

  35. Van Geelen JM, van de Weijer PH, Arnolds H. (1996) Urogenital symptoms and their resulting discomfort in non-institutionalized 50-to-75-year-old Dutch women. Ned Tijdschr Geneeskd 140:713–716.

    PubMed  Google Scholar 

  36. Stenberg A, Heimer G, Ulmsten U. (1995) The prevalence of urogenital symptoms in postmenopausal women. Maturitas 22(Suppl):S17–S20.

    Article  PubMed  Google Scholar 

  37. Spector IP, Carey MP. (1990) Incidence and prevalence of the sexual dysfunctions: a critical review. Arch Sex Behav 19:389–409.

    Article  PubMed  CAS  Google Scholar 

  38. Leiblum SR, Wiegel M. (2002) Psychotherapeutic interventions for treating female sexual dysfunction. World J Urol 20:127–136.

    Article  PubMed  Google Scholar 

  39. Burnett AL, Calvin DC, Silver RI, et al. (1997) Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol 158:75–78.

    Article  PubMed  CAS  Google Scholar 

  40. Palle C, Bredjkaer HE, Ottesen B, et al. (1990) Vasoactive intestinal polypeptide and human vaginal blood flow: comparison between transvaginal and intravenous administration. Clin Exp Pharmacol Physiol 17:61–68.

    Article  PubMed  CAS  Google Scholar 

  41. Berman JR, Berman LA, Toler SM, et al. (2004) Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal dysfunction: a double blind placebo controlled study. J Urol 170(6 pt 1):2333–2338.

    Google Scholar 

  42. Sipski M, Rosen RC, Alexander CJ, et al. (2000) Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury. Urology 55:812–815.

    Article  PubMed  CAS  Google Scholar 

  43. Caruso S, Intelisano G, Lupo L, et al. (2001) Premenopausal women affected by sexual arousal disorder treated with Sildenafil: A double blind, crossover, placebo-controlled study. Brit J Obstet Gynaecol 108:623–628.

    Article  CAS  Google Scholar 

  44. Shen WW, Urosevich Z, Clayton DO. (1999) Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. J Reprod Med 44:535–542.

    PubMed  CAS  Google Scholar 

  45. Lobo RA. (2001) Androgens in postmenopausal women: production, possible role, and replacement options. Obstet Gynecol Surv 56:361–376

    Article  PubMed  CAS  Google Scholar 

  46. Guay A, Davis SR. (2002) Testosterone insufficiency in women: fact of fiction? World J Urol 20:106–110.

    Article  PubMed  CAS  Google Scholar 

  47. Guay AT. (2001) Decreased testosterone in regularly menstruating women with decreased libido: a clinical observation. J Sex Marital Ther 27:513–519.

    Article  PubMed  CAS  Google Scholar 

  48. Guay AT, Jacobson J. (2002) Decreased free testosterone and dehydroepiandrosterone-sulfate (DHEA-S) levels in women with decreased libido. J Sex Marital Ther 28(Suppl 1):129–142.

    Article  PubMed  Google Scholar 

  49. Shifren JL, Baunstein GD, Simon JA, et al. (2000) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343:682–688.

    Article  PubMed  CAS  Google Scholar 

  50. Tuiten A, Van Honk J, Koppeschaar H, et al. (2000) Time course and effects of testosterone administration on sexual arousal in women. Arch Gen Psychiatry 57:149–153.

    Article  PubMed  CAS  Google Scholar 

  51. Arlt W, Callies F, Van Vlijmen JC, et al. (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013–1020.

    Article  PubMed  CAS  Google Scholar 

  52. Davis SR, Walker KZ, Strauss BJ. (2000) Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women. Menopause 7:395–401.

    Article  PubMed  CAS  Google Scholar 

  53. Billups KL. (2002) the role of mechanical devices in treating female sexual dysfunction and enhancing the female sexual response. World J Urol 20:137–141.

    Article  PubMed  Google Scholar 

  54. Hurlbert DF. (1995) The coital alignment technique and directed masturbation: a comparative study on female orgasm. J Sex Marital Ther 21:21–29.

    PubMed  CAS  Google Scholar 

  55. Wilson SK, Delk II JR, Billups KL. (2001) Treating symptoms of female sexual arousal disorder with the eros clitoral therapy device. J Gend Specif Med 4:54–58.

    PubMed  CAS  Google Scholar 

  56. Shabsigh R, Kimoto Y, Amar E, et al. (2004) Economical aspects of sexual dysfunction. In: Jardin A, Wagner G, Khouri S, Giuliano F, Lue TF, Rosen R, eds., Erectile and Sexual Dysfunction, 2nd International Consultation on Erectile and Sexual Dysfunction co-sponsored by the World Health Organization (WHO), International Society of Sexual and Impotence Research (ISSIR) and Societe Internationale d’Urologie (SIU), Health Publications Ltd., pp. 53–64.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Shabsigh, R., Davis, A.R., Anastasiadis, A.G., Makhsida, N., Yan, G. (2005). Female Sexual Dysfunction. In: Broderick, G.A. (eds) Oral Pharmacotherapy for Male Sexual Dysfunction. Current Clinical Urology. Humana Press. https://doi.org/10.1385/1-59259-871-4:423

Download citation

  • DOI: https://doi.org/10.1385/1-59259-871-4:423

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-451-7

  • Online ISBN: 978-1-59259-871-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics